Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Typical isn't it!!!!!!
No communication today...
My daughter received a call from XXII on my phone. I am travelling overseas dont carry my phone with me when I do. Does anyone else received a call from XXII. If so what is it about. Care to share!!!!
Oh yeah only a guy who said that!!!!
What the f happened droped 5.5%?????
Cant agree more...
One of posters on Yahoo posted below article from Asia dated 07/26/2018
Clock Ticking for FDA’s “Nicotine Limit” Rule
by Thomas Schmid July 26, 2018
RSSPrint
Expand
18i3_Clock_Ticking
Tobacco plants cultivated in 22nd Century’s grow room
Following its recent ANPRM, the United States’ FDA is set to eventually enact a new rule requiring all cigarettes sold in the country to have “minimally or non-addictive” nicotine levels. While the news has unsettled a good many players, there is at least one company that awaits that moment well prepared.
By Thomas Schmid
It caused quite a stir among tobacco companies in the United States and elsewhere when US Food and Drug Administration (FDA) commissioner Dr. Scott Gottlieb in July 2017 dropped his bombshell announcing that the federal agency would introduce a new regulation that would limit nicotine in cigarettes to “minimally or non-addictive levels.” It had long been known, Gottlieb said at the time, that nicotine is the primary addictive component of cigarettes and if smokers lost their addiction, they’d be “free to choose when and how often to smoke.” By extension, limiting nicotine in cigarettes could save millions of lives, help current smokers kick their habit, as well as prevent countless future smokers from picking up a nicotine addiction.
Gottlieb’s bombshell didn’t just “evaporate into thin smoke,” so to speak, as some tobacco industry executives had perhaps hoped for. On March 16 of this year, FDA embarked on the first step in the rule-making process by issuing an Advance Notice of Proposed Rule Making (ANPRM) to obtain information “for consideration in developing a tobacco product standard to set the maximum nicotine level for cigarettes.” Stakeholders – tobacco growers, manufacturers, academic institutions, public health organizations, NGOs - were given until July 16 to submit detailed arguments why – or why not – the proposed new regulation should be introduced, particularly “scientific data and research relevant to the empirical basis for regulatory decisions related to a potential nicotine product standard.” Due to the obvious complexity of the subject matter paired with the ramifications that it carries for tobacco producers and manufacturers alike, the ANPRM posting now suddenly got stakeholders scrambling head over heels, with several of them filing requests for an extension of the comment period.
It is helpful to know at this point that FDA already was granted legal authority to formulate a rule to lower the amount of nicotine in cigarettes when the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) was signed into law on June 22, 2009. While that law does not allow FDA to use its new product standard authority to reduce nicotine yields of a tobacco product to zero, it grants the agency the power to determine whether nicotine can be reduced to levels that do not cause or sustain addiction, and, if so, to require the reduction of nicotine yields to those levels. Hence, the tobacco industry at large should have recognized the signs almost a decade ago that a nicotine-curtailing rule might emerge sooner rather than later. But, it appears that almost nobody devised any concrete measures to be prepared when and if that would happen. While it can still take years before the new rule is effective, the clock is definitely ticking, and the countdown already started with Gottlieb’s announcement.
18i3_Clock_Ticking
22nd Century developed breakthrough tobacco-modifying biotechnology
Dawn of the 22nd Century
Enter 22nd Century Group Inc., a plant biotechnology company headquartered in the small town of Williamsville, New York. The New York Stock Exchange-listed enterprise (ticker symbol XXII) invested years of research and countless millions of dollars into its stated mission “to reduce the harm caused by smoking.” Among the company’s most important achievements to-date are the development of a proprietary genetic engineering technology that allows it to regulate the level of nicotine (and other nicotinic alkaloids) in the tobacco plant itself, as well as the development of Spectrum®, a very-low nicotine content (VLNC) research cigarette brand used in a long line of independent studies and clinical trials on smoking cessation and harm reduction.
A New Breed of Tobacco
22nd Century Group claims to be “the only company in the world growing virtually nicotine-free tobacco,” according to communications director James Vail. To make this clear: the company’s scientists have genetically modified the tobacco plant in such a way that during its natural growing phase it develops at least 95% less nicotine than conventional strains of the tobacco plant. That means that after harvesting and curing, no special extraction process needs to be utilized to artificially reduce the nicotine content to the desired level. Cigarettes made from 22nd Century’s tobacco automatically yield the “minimally or non-addictive levels” of nicotine FDA is pushing for. “Our tobacco is grown with very low levels of nicotine and no [later] extraction process is needed,” confirmed Juan Sanchez Tamburrino, Ph.D., the company’s vice president of research and development.
18i3_Clock_Ticking
Henry Sicignano III, left, and Juan Sanchez Tamburrino
Such post-harvest extraction processes do of course exist, whereas the naturally-high nicotine content of tobacco can be lowered by applying steam, a solvent, or a so-called supercritical fluid process. But, the downside of all these methods is that they also remove other substances from the tobacco that are crucially important to its sensory properties, negatively affecting a cigarette’s taste characteristics and aroma. In short, it tastes and smells flat, shallow, and unexciting. By contrast, “22nd Century Group’s technology offers a viable alternative to more costly and detrimental extraction-based processes which have a significant impact on taste profiles,” Tamburrino said.
With its modified tobacco plants already being grown in quasi-commercial quantities on a number of independently-owned farms in the US, 22nd Century uses the tobacco in a number of intuitive products, including its SPECTRUM® research cigarettes (see below). To assert and protect its intellectual property rights, the company currently holds a significant number of issued and pending patent applications around the world, including for the above mentioned tobacco-modifying biotechnology.
18i3_Clock_Ticking
SPECTRUM menthol, regular packs
The SPECTRUM® of Things
In partnership with independent researchers and officials from the National Institute on Drug Abuse (NIDA), the FDA, the National Cancer Institute (NCI), and the Center for Disease Control and Prevention (CDC), 22nd Century Group developed the ground-breaking SPECTRUM® research cigarettes. Not commercially available and solely deployed in independent research projects and studies, the main SPECTRUM® product line consists of a series of cigarette styles that vary nicotine yields over a 50-fold range – from very low nicotine yield (98% less nicotine than conventional brands - 0.4mg/g vs. 20mg/g) to relatively high yields.
As a subcontractor under federal government contracts, the company so far has supplied over 24 million SPECTRUM® cigarettes for NIDA, which is part of the National Institutes of Health (NIH). The cigarettes have been used in numerous high-profile studies by independent university researchers on smoking cessation and smoking behavior. The gist of these and other clinical trials that have been published in peer-reviewed articles and altogether have used a budget exceeding $100 million paid for by agencies of the US federal government has been that VLNC cigarettes (i.e. cigarettes containing only about 0.30mg nicotine per stick as opposed to the 12-17mg typical in commercial brands) are much more effective in helping people to quit smoking or reducing their consumption than other aids, such as nicotine patches, vaping, or nicotine chewing gums. “22nd Century’s SPECTRUM® cigarettes have facilitated numerous of independent studies that have demonstrated, conclusively, the public health benefits of minimally or non-addictive cigarettes,” explained Henry Sicignano III, the company’s president and chief executive officer. “What’s more,” he said, “is that 22nd Century’s proprietary very low nicotine content cigarettes show that FDA’s plan to mandate dramatically reduced nicotine levels in cigarettes is immediately feasible. We are proud to be a part of this exceptionally important public health initiative.”
18i3_Clock_Ticking
Modified tobacco plants are grown in independently owned farms in the US
The “Brand A” MRTP Application
SPECTRUM® cigarettes are exclusively used in research and not sold to end consumers in retail stores. But, this may change in the not too distant future. 22nd Century is soon going to refile a revised modified risk tobacco product (MRTP) application with FDA for an in-house developed commercial cigarette brand, currently identified with the placeholder brand name “Brand A”. If “Brand A” is approved and recognized as a genuine MRTP, it will break a long-standing spell, as to-date not one single tobacco company has succeeded with any MRTP application. “We are moving forward with a significantly expanded MRTP application with the FDA’s Center for Tobacco Products for the company’s Brand A cigarettes containing our proprietary VLN™ tobacco that has at least 95% less nicotine content than tobacco used in conventional cigarettes,” asserted James Vail.
He elaborated that Brand A cigarettes contain approximately 0.30mg nicotine per stick, or less than 0.05mg nicotine yield per cigarette. In each case, he said, this represented a “reduction of at least 95% less nicotine relative to ‘Big Tobacco’ cigarette brands.” “The company’s MRTP application to the CTP/FDA will request that Brand A packaging and marketing be allowed to disclose to consumers that the cigarettes reduce smokers’ exposure to nicotine,” Vail added. Like SPECTRUM®, Brand A will be made from the company’s proprietary, biotechnologically-engineered VLN™ tobacco. And since that tobacco has not been subjected to physical or chemical manipulation to remove its nicotine, the cigarettes will have the taste and sensory characteristics of conventional cigarettes. “We believe Brand A containing our proprietary VLN™ tobacco will prove invaluable in drastically reducing smokers’ exposure to nicotine,” explained Sicignano. “To this end, 22nd Century looks forward to continuing to work closely with FDA on this very important public health matter.”
So, there we have it. It is only going to be a matter of time before the new FDA rule will be upon us. That even could happen in less than two years, if some of the stakeholders have their way. In an open letter to FDA’s Commissioner dated May 21, 2018, a total of 41 undersigned top-of-the-tier public health and medical organizations in the U.S. called for the new rule to be finalized by March 2019 and take effect by March of 2020. The question on many tobacco firm executives’ minds around the world also is whether the FDA rule is going to have a domino effect. Historically, many countries – particularly in Europe – have regularly felt compelled to follow suit with their own corresponding rules whenever FDA had enacted an important new regulation.
cigarettes FDA United States government nicotine regulations addiction Food and Drug Administration
by Thomas Schmid July 26, 2018
Read Tobacco Asia Online
????????????
Click Here for Chinese language version
See Our E-Magazine Archive
Home News Features Manufacturing Leaf Products E-Cigs Events Suppliers Guide E-Mag
Advertising Opportunities |
Contact Us |
Subscribe to Tobacco Asia
| Past Issues
© 2015 October Multimedia Co., Ltd - Tobacco Industry magazine reporting on cigarettes, e-cigarettes, cigars, RYO, bidis, kretek, cigarillos, chewing tobacco, tobacco equipment, tobacco machinery, tobacco packaging machinery, make-pack machines, news, Indonesia and China
Down the hill from here......
Too long green, time to turn red!!!!!!!!
It is greennn. So surprised. XXII broke a leg huh.....
Expect big drop in pps today. Such a great news deserve a big drop!!!!!!!!
Where is everybody cat is out of the bag. BT trying to catch it.....
Altria publish an article how low nicotine decision by FDA will cost 900t thousand jobs and US jobless claim will jump to 4.6% from current 3.9%. Now they started the scare tactics.
Altria Thinks Low-Nicotine Cigarettes Could Lead to About a Million Lost Jobs
By Uliana Pavlova
July 17, 2018, 4:05 PM EDT
LISTEN TO ARTICLE
1:52
SHARE THIS ARTICLE
Facebook
Twitter
LinkedIn
Email
In this article
MO
ALTRIA GROUP INC
57.41USD+0.06+0.10%
Altria Group Inc. says lower nicotine means lower employment -- to the tune of almost a million jobs.
As the comment period on proposed new rules for cigarettes came to an end Monday, the tobacco industry has weighed in. It’s predicting dire consequences if the Food and Drug Administration carries out a plan it’s considering that would lower nicotine in cigarettes by as much as 97 percent.
Employment Risk
Altria says 951,000 U.S. jobs could go up in smoke with low-nicotine rule
Source: Altria comments with FDA
Note: Shows the high end of estimate. Company forecasts as many as 317,000 workers would find new employment, resulting in lower net losses
Altria, the maker of Marlboros for the U.S. market, said the measure would cause the loss of as many as 951,000 jobs, directly and indirectly, throughout the U.S. The Richmond, Virginia-based company, which had about 8,300 employees as of the end of 2017, estimates that tobacco growers, manufacturers, wholesalers, retailers and distributors would all feel the impact.
By Altria’s calculations, the nation’s unemployment rate could rise from 3.9 percent to 4.5 percent if a very-low nicotine standard were put in place. A slight pick up in employment at e-vapor retailers would help offset job losses, but not in a substantial way, the company said. It declined to forecast its own job losses when contacted by Bloomberg News.
ITG Brands, the producer of Winston and Kool cigarettes, also commented, arguing that the proposed changes would give underage users greater access to cigarettes because a lower nicotine standard would create a robust black market. Meanwhile, Reynolds American executive Michael Ogden said in comments that it could take more than 20 years for the company to meet the low-level nicotine requirement, depending on the what the FDA’s rules look like.
The FDA says the measure would give addicted users “the choice and ability to quit more easily.” The agency estimates that mandating that cigarettes contain minimally or non-addictive levels of nicotine would prevent more than 33 million people, primarily youth and young adults, from becoming regular smokers by the end of the century.
Have a confidential news tip? Get in touch with our reporters. Before it's here, it's on the Bloomberg Terminal. LEARN MORE
UP NEXT
J&J Unit to Sell Sylvant Rights to U.K. Drugmaker Eusa Pharma
by Taboola Sponsored Links From The Web
If You're Over 30 And Own A Computer, This Game Is A Must-Have!
Vikings: Free Online Game
Language expert shares the secret to learning a language in 20 mins a day
Babbel
CPAP Makers Scrambling After New Snoring Fix Unveiled
My Snoring Solution
Hotels In Turkey At Ridiculously Low Prices
Save70.com
Meet the 10 Richest People in the World
Work + Money
How this little device keeps you cool wherever you are...
CoolAir
LIVE ON BLOOMBERG
Watch Live TV
Listen to Live Radio
Most Read
TECHNOLOGY
Amazon Suffers Tech Crash and Strikes During Prime Day
TECHNOLOGY
Jeff Bezos Becomes the Richest Man in Modern History, Topping $150 Billion
TECHNOLOGY
Google Fined Record $5 Billion by EU, Given 90 Days to Stop ‘Illegal Practices’
updated 2 hours ago
BUSINESS
MGM Sues Vegas Mass-Shooting Victims in Hopes of Limiting Liability
BUSINESS
Musk Apologizes to U.K. Diver He Labeled as Pedophile
You are very careful also.... You got me rather my fat finger.... XXII will get you be aware if you are short...
Ney sayers are having a field day....
I presume not too many investors are convinced the power of XXII and still shorting like crazy....
How come if it is so expensive to borrow the shorts are keep on shorting? To lose their shirt or they know something we dont know??? Such a positive note today and stock is down 5% can't put my arm around it.....
Speechless. as of now XXII is down $0.02!!!!!???????######&&&&&&&&%%%%%%%*******$$$$$$$
I am more on the side that BT is the one funding these non sense articles....
Motley fool is bombarding negatively XXII prior to July 16. Latest article claims that XXII has lost its leadership in marijuana market and left with one shot wonder that is dependent upon FDA's decision on reducing nicotine levels where timing can be within 5 years!!!!. Hence it is not a reliable investment????
Read Motley Fools today's article on XXII. In summary they are saying w/o FDA approval of lower nicotine level XXII recent pps increase can/will bounce back so be careful investors. Typical uh....
Go figure....
I really dont get this. 200,000 shares changes hand at a price of $2.80 and some schmuck gets it down to $2.69 with 200 shares.... Can someone shed a light on this mickey mouse game....
Yeah I know the FDA targeted level is %0.4. CNBC was reporting JUUL nicotine level is 5% in August they will introduce 3% level product... Whether 3% or 5% it is a crime....
It is amazing to read JUUL will introduce new product with 3% nicotine vs. their current 5%. Is the market warming up to the reduced nicotine concept???? By the way 3% is as mean as 5%....
For a change hopefully will close green today....
It is getting more and more obvious that all shorts and non beleiving investors are playing on the wrong horse. Tsunami is approaching with all its vengence.....
But pps is going down regardless of great news!!!! What is new????
Nice find. It is funny that all the anti comments are from individuals but none from any reputable institute. So FDA will consider those individuals who is highlighting their individual preferences w/o any scientific facts !!!!!! Really will they?????
Not about selling and/or buying just facts...
Russell 2000 hits all time high. XXII is still going down and down.....
I guess we will all find out sooner then later....
I totally agree with you. None of the big T want to blink first waiting the other to do so then hell will break loose....
Talking to XXII. Aren't you tired of this yo-yo game. Up 6% down 4% up 14% then down 8% , on and on....
Sick and tired of this yo yo game. Make a decision what ever going to happen let it happen for gods sake!!!!!!!
Bonnie claims 5 years for nicotine restriction. Is it a wish or a fact?
Should read 30 days...
#0 days extension instead of requested 90 days gave monkeys reason to take the pps down.
Any time you think there is a good news for XXII, pps drops 4-5%????
Can't wait since 2013....